Clinical Trials Directory

Trials / Terminated

TerminatedNCT01173848

Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients

A Randomized Study to Evaluate the Effectiveness of Cholecalciferol Versus Ergocalciferol Following Kidney Disease Outcomes Quality Initiative (K/DOQI) Guidelines for Vitamin D Therapy in Stages 3 & 4 Chronic Kidney Disease (CKD) Patients

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
19 (actual)
Sponsor
The Cleveland Clinic · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the effectiveness of vitamin D3 versus vitamin D2 in raising vitamin D levels and suppressing parathyroid hormone levels in patients with kidney disease who are not on dialysis.

Detailed description

Subjects will be randomized and assigned to one of the treatment groups (D2 or D3). Subjects will be dispensed a supply of 1.25 mg cholecalciferol/ergocalciferol tablets, depending on their randomization outcome. The number of pills dispensed and medication instructions will be determined by their 25OHD level and K/DOQI guidelines. Both Study personnel and subject will be blinded to randomization group. The treatment phase will be 24 weeks in duration with lab visits every 6 weeks. All laboratory specimens will be drawn either at CCF Main hospital labs or at a CCF family Health center lab. Subjects will be have telephone interviews at week 4, 10, 16, 22 and possibly at weeks 28 and 34.

Conditions

Interventions

TypeNameDescription
DRUGErgocalciferol1.25mg weekly for 12 weeks then once a month for 3 months. or 1.25 weekly for 4 weeks then once a month for 5 months. or 1.25 monthly for 6 months
DRUGCholecalciferol1.25 weekly for 12 weeks then monthly for 3 months or 1.25 weekly for 4 weeks then monthly for 5 months or 1.25 monthly for 6 months

Timeline

Start date
2010-07-01
Primary completion
2011-09-01
Completion
2011-10-18
First posted
2010-08-02
Last updated
2017-04-04
Results posted
2017-04-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01173848. Inclusion in this directory is not an endorsement.